Biohaven Ltd.
BHVN
$14.85
-$2.35-13.66%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 27.33M | 33.98M | 22.46M | 20.56M | 18.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 211.70M | 221.56M | 179.03M | 178.17M | 161.87M |
| Operating Income | -211.70M | -221.56M | -179.03M | -178.17M | -161.87M |
| Income Before Tax | -197.89M | -221.07M | -186.80M | -160.36M | -319.59M |
| Income Tax Expenses | 261.00K | 609.00K | 48.00K | -59.00K | 177.00K |
| Earnings from Continuing Operations | -198.15M | -221.68M | -186.84M | -160.30M | -319.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -198.15M | -221.68M | -186.84M | -160.30M | -319.77M |
| EBIT | -211.70M | -221.56M | -179.03M | -178.17M | -161.87M |
| EBITDA | -209.72M | -219.32M | -176.57M | -176.17M | -159.92M |
| EPS Basic | -1.94 | -2.17 | -1.85 | -1.70 | -3.64 |
| Normalized Basic EPS | -1.23 | -1.38 | -1.13 | -1.10 | -1.09 |
| EPS Diluted | -1.94 | -2.17 | -1.85 | -1.70 | -3.64 |
| Normalized Diluted EPS | -1.23 | -1.38 | -1.13 | -1.10 | -1.09 |
| Average Basic Shares Outstanding | 102.37M | 101.94M | 101.05M | 94.37M | 87.77M |
| Average Diluted Shares Outstanding | 102.37M | 101.94M | 101.05M | 94.37M | 87.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |